PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.\', \'Harvard Medical School, Boston, MA, USA.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.\', \'University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA.\', \'Bioqual, Rockville, MD, USA.\', \'Janssen Vaccines & Prevention, Leiden, The Netherlands.\', \'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dbarouch@bidmc.harvard.edu.\', \'Harvard Medical School, Boston, MA, USA. dbarouch@bidmc.harvard.edu.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41586-021-03732-8
?:hasPublicationType
?:journal
  • Nature
is ?:pmid of
?:pmid
?:pmid
  • 34161961
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.875
?:rankingScore_hIndex
  • 1052
is ?:relation_isRelatedTo_publication of
?:title
  • Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all